The safety profile of infliximab in patients with Crohn’s disease: The Mayo Clinic experience in 500 patients
JCJean‐Frédéric ColombelEVEdward V. LoftusWJWilliam J. TremaineLJLaurence J. EganWSWilliam S. Harmsen
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
906
total citations
- FWCI
- 38.88
- Percentile
- 100%
- References
- 44
Citations per year
Authors
8Topics & keywords
Topics
Keywords
- Infliximab
- Medicine
- Adverse effect
- Internal medicine
- Pneumonia
- Surgery
- Crohn's disease
- Inflammatory bowel disease
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.